>
Cognetivity Neurosciences logo

CGN - Cognetivity Neurosciences Share Price

C$0.51 -0.1  -8.9%

Last Trade - 14/04/21

Sector
Healthcare
Size
Micro Cap
Market Cap £19.8m
Enterprise Value £19.9m
Revenue £n/a
Position in Universe 1340th / 2712
Bullish
Bearish
Unlock CGN Revenue
Momentum
Relative Strength (%)
1m -24.3%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -37.8%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Jan 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
0.000 0.000 0.000 0.000 0.000 0.000
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the nine months ended 31 October 2020,Cognetivity Neurosciences Ltd revenues was not reported.Net loss decreased 60% to C$916K. Lower net loss reflectsResearch and development decrease from C$672K (expense) toC$41K (income), Other income increase from C$1K to C$580K(income), Marketing and advertising decrease of 90% toC$34K (expense). Basic Earnings per Share excludingExtraordinary Items increased from -C$0.05 to -C$0.02.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

CGN Revenue Unlock CGN Revenue

Net Income

CGN Net Income Unlock CGN Revenue

Normalised EPS

CGN Normalised EPS Unlock CGN Revenue

PE Ratio Range

CGN PE Ratio Range Unlock CGN Revenue

Dividend Yield Range

CGN Dividend Yield Range Unlock CGN Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
CGN EPS Forecasts Unlock CGN Revenue
Profile Summary

Cognetivity Neurosciences Ltd is Canada-based technology company, engaged in developing a cognitive testing platform, the Integrated Cognitive Assessment (ICA), for use in medical and commercial environments. The ICA platform uses artificial intelligence and machine learning techniques to help detect the earliest signs of impairment by testing the performance of the brain, potentially allowing early diagnosis of dementia. The Company aims to develop the ICA through planned clinical studies to the market in North America and Europe.

Directors
Last Annual January 31st, 2020
Last Interim October 31st, 2020
Incorporated December 11, 2015
Public Since March 19, 2018
No. of Shareholders: n/a
No. of Employees: n/a
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index
Exchange Canadian Securities Exchange
Shares in Issue 61,009,357
Free Float (0.0%)
Eligible for
ISAs
SIPPs
CGN Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for CGN
Upcoming Events for CGN
Frequently Asked Questions for Cognetivity Neurosciences
What is the Cognetivity Neurosciences share price?

As of 14/04/21, shares in Cognetivity Neurosciences are trading at C$0.51, giving the company a market capitalisation of £19.8m. This share price information is delayed by 15 minutes.

How has the Cognetivity Neurosciences share price performed this year?

Shares in Cognetivity Neurosciences are currently trading at C$0.51 and the price has moved by 0.331k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Cognetivity Neurosciences price has moved by 0.220k% over the past year.

What are the analyst and broker recommendations for Cognetivity Neurosciences?

There are no analysts currently covering Cognetivity Neurosciences.

When will Cognetivity Neurosciences next release its financial results?

Cognetivity Neurosciences is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-10-31
What is the Cognetivity Neurosciences dividend yield?

Cognetivity Neurosciences does not currently pay a dividend.

Does Cognetivity Neurosciences pay a dividend?

Cognetivity Neurosciences does not currently pay a dividend.

When does Cognetivity Neurosciences next pay dividends?

Cognetivity Neurosciences does not currently pay a dividend.

How do I buy Cognetivity Neurosciences shares?

To buy shares in Cognetivity Neurosciences you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Cognetivity Neurosciences?

Shares in Cognetivity Neurosciences are currently trading at C$0.51, giving the company a market capitalisation of £19.8m.

Where are Cognetivity Neurosciences shares listed? Where are Cognetivity Neurosciences shares listed?

Here are the trading details for Cognetivity Neurosciences:

Country of listing: Canada
Exchange: CNX
Ticker Symbol: CGN
What kind of share is Cognetivity Neurosciences?

Based on an overall assessment of its quality, value and momentum, Cognetivity Neurosciences is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Cognetivity Neurosciences share price forecast 2021?

We were not able to load any forecast data for Cognetivity Neurosciences.

How can I tell whether the Cognetivity Neurosciences share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Cognetivity Neurosciences. Over the past six months, the relative strength of its shares against the market has been 33.18%. At the current price of C$0.51, shares in Cognetivity Neurosciences are trading at 45.21% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Cognetivity Neurosciences PE Ratio?

We were not able to find PE ratio data for Cognetivity Neurosciences.

Who are the key directors of Cognetivity Neurosciences?

We were unable to find the directors for Cognetivity Neurosciences.

Who are the major shareholders of Cognetivity Neurosciences?

Here are the top five shareholders of Cognetivity Neurosciences based on the size of their shareholding:

Habibi (Sina) Individual Investor
Percentage owned: 16.16% (8.00m shares)
Phillips (Mark Alwyn) Individual Investor
Percentage owned: 1.65% (816k shares)
Kalafatis (Christos) Individual Investor
Percentage owned: 1.32% (653k shares)
Next Edge Capital Corp. Hedge Fund
Percentage owned: 1.06% (522k shares)
Next Edge Bio-Tech Plus Class Hedge Fund Portfolio
Percentage owned: 1.06% (522k shares)
Similar to CGN
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.